Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new pan-divisional initiative has launched at the University of Oxford, bringing together the collective force of cancer research, outreach and care that happen across the city of Oxford.

Overlapping images of medical research, a young child and a brain scan © Oxford Cancer

Cancer remains the second leading cause of death worldwide, with an estimated 10 million cancer mortalities in 2020 alone. It continues to be a barrier to increasing life expectancy in every country of the world.

Today Oxford Cancer launches at the University of Oxford – a new pan-divisional research theme which has been established to support researchers across the city of Oxford in solving the key challenges in cancer research. Through this network, Oxford is tackling the biggest questions and highlights Oxford’s commitment to cancer as one of its strategic research themes.

Oxford has over 900 cancer researchers based across the University and Hospitals Foundation Trust, with academic strengths in a wide variety of areas, including immunology, data science, cell biology, physical science & drug development. Bringing together this expertise is what Oxford Cancer aims to do, in order to facilitate multi-disciplinary research across its partners. It ultimately aims to solve the key challenges cancer represents through developing and delivering novel strategies for early detection and curative treatment of a range of different cancer types. This approach will be informed by the latest fundamental scientific discoveries and underpinned by world leading data science and technological developments that are unique to Oxford.

“Through Oxford Cancer, our mission is to enable and combine the best research and clinical resources in order to innovate cancer treatment and care world-wide. We aim to do this through discovery, collaboration and education – and empowered by the strategic leadership and world-leading facilities here in Oxford.”

  • Professor Tim Elliott, co-Director, Oxford Cancer.

“With over 900 researchers across 20+ departments and 5 University & OUH divisions, cancer research is everywhere in Oxford. We are very excited to launch the new Oxford Cancer network, with the aim of bringing together all those with a shared interest in cancer, to address urgent and emerging cancer patient needs, informed by the best basic science”

  • Professor Mark Middleton, co-Director, Oxford Cancer

Oxford Cancer also coordinates a variety of researcher support services, for Oxford researchers and their partner organisations, to help break down barriers to accessing key expertise and enhance the patient impact of their work.

For more information about this new network, it’s strategic research themes, services and latest news from the Oxford Cancer community, please check out the new Oxford Cancer website and the launch FAQs.

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.